How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/life-threatening-ventricular-tachycardia.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-11 · How we verify

Life-Threatening Ventricular Tachycardia — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Life-Threatening Ventricular Tachycardia (disease) competitive landscape: 6 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

6 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Life-Threatening Ventricular Tachycardia, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Bretylium Tosylate	BRETYLIUM	Pfizer	bretylium	Beta-1 adrenergic receptor	1986-01-01
Cordarone	AMIODARONE	Pfizer	Antiarrhythmic	sodium channels, potassium channels, calcium channels	1985-01-01
Inderal	propranolol	Generic (originally ICI/AstraZeneca)	Non-selective beta-blocker	Nuclear receptor subfamily 2 group E member 1, 5-hydroxytryptamine receptor 6, Cytochrome P450 1A2	1967-11-13
Isocain	PROCAINE	Pfizer	Amide Local Anesthetic [EPC]	5-hydroxytryptamine receptor 3A	1954-01-01
Quinidine Gluconate	QUINIDINE SULFATE	Eli Lilly	Antiarrhythmic	Muscarinic acetylcholine receptor M2	1950-01-01
Betapace	sotalol	Bayer		Beta-1 adrenergic receptor, Beta-2 adrenergic receptor, Potassium voltage-gated channel subfamily H member 2

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Pfizer · 3 drugs in Life-Threatening Ventricular Tachycardia
· 1 drug in Life-Threatening Ventricular Tachycardia
Bayer · 1 drug in Life-Threatening Ventricular Tachycardia
Eli Lilly · 1 drug in Life-Threatening Ventricular Tachycardia
Generic (originally ICI/AstraZeneca) · 1 drug in Life-Threatening Ventricular Tachycardia

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Life-Threatening Ventricular Tachycardia:

Cite this brief

Drug Landscape (2026). Life-Threatening Ventricular Tachycardia — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/life-threatening-ventricular-tachycardia. Accessed 2026-06-11.

Life-Threatening Ventricular Tachycardia full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing